Firefly Neuroscience Inc (AIFF) - Expected earnings per share growth for next year
The projected net profit growth of Firefly Neuroscience, Inc (AIFF) demonstrates the company's resilience to geopolitics due to the US localization of its AI services. The 0.00 mark reflects fresh data, confirming demand for AI diagnostics for dementia and depression. The deployment of the BrainScope cloud system automates brain scanning, which stabilizes the indicator's dynamics and eliminates sharp fluctuations in the share price within a sideways corridor.
Metric breakdowns and analytics for Firefly Neuroscience Inc (AIFF)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization information:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Firefly Neuroscience, Inc|AIFF - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Firefly Neuroscience, Inc.|AIFF - Company Aggregate Debts|Debt to Book Capitalization Ratio Firefly Neuro|AIFF - Company Long-Term Loans and Borrowings|Company Short-Term Debt Firefly Neuroscience|Quick Liquidity fireflyneuro.com
- earnings and market ratios statistics:
AIFF - Net Financial Result|Projected Future Earnings Firefly Neuroscience, Inc|AIFF - Price to Earnings Ratio|Forward P/E Multiple Firefly Neuroscience, Inc.|AIFF - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Firefly Neuroscience|AIFF - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Firefly Neuroscience|AIFF - Earnings per share for the last 12 months|Quarterly EPS earnings growth fireflyneuro.com|AIFF - Net earnings per share growth this year|Earnings growth forecast for next year Firefly Neuroscience, Inc
- sales and revenue indicators:
Basic company analysis:AIFF, Firefly Neuroscience, Inc
This indicator reflects the expected earnings momentum for the upcoming period, measuring the business model's ability to generate incremental revenue relative to current values. The calculation is based on analyst consensus forecasts, which are sensitive to any changes in operating reports and market quotes. By analyzing the projected growth in net income for Firefly Neuroscience, Inc (AIFF), investors can see the impact of the company's expansion into the US neurological sector and the monetization of FDA-approved AI technologies.
Competitor analysis for Firefly Neuroscience, Inc
Net earnings per share growth forecast for next year Biogen|Expected earnings per share growth for next year neurocrine.com (NBIX)|Net earnings per share growth forecast for next year Regencell Bioscience Holdings Limited (RGC)|AXSM (Axsome Therapeutics Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Expected earnings per share trend next year XENE|Viking Therapeutics - Earnings growth forecast for next year|Expected earnings per share trend next year SUPN (supernus.com)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Denali (DNLI)|Net earnings per share growth forecast for next year harmonybiosciences.com|BHVN (Biohaven Pharmaceutical) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year amylyx.com (AMLX)|TRVI: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Praxis Precision Medicines Inc PRAX|Consensus forecast of earnings per share growth for next year Anavex Life Sciences Corp. (AVXL)|CeriBell EEG - Earnings growth forecast for next year|Expected net earnings per share growth next year Prothena Corp|ALEC: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ANNX|OMER (Omeros) - Earnings growth forecast for next year|NGNE - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year AC Immune Corp (ACIU)|Projected earnings per share increase next year VYGR|Earnings growth forecast for next year NMRA (neumoratx.com)|SCLX - Expected earnings per share growth for next year|tevogen.com - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Alpha Cognition Inc. (ACOG)|CGTX: Earnings growth forecast for next year|IKT - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year SAVA|Expected earnings per share growth for next year Assertio (ASRT)|Expected earnings per share growth for next year COYA (Coya)|Net earnings per share growth forecast for next year VTGN (VistaGen Therapeutics Inc)|Net earnings per share growth forecast for next year Ovid Therapeutics OVID|Earnings growth forecast for next year Acumen Pharma ABOS|CervoMed, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year ATHE (alteritytherapeutics.com)|CLNN (Clene Nanomedicine) - Expected earnings per share growth for next year|Expected net earnings per share growth next year PepGen Corp (PEPG)|Net earnings per share growth forecast for next year Jupiter Neurosciences Inc|Expected net earnings per share growth next year Relmada Therapeutics RLMD|Net earnings per share growth forecast for next year Annovis Bio (ANVS)|GRCE - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|NRSN: Projected earnings per share growth rate for next year|RVPH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year MetaVia MTVA|neuraxis.com (NRXS) - Net earnings per share growth forecast for next year|Helius Medical Technologies Inc. - Expected earnings per share trend next year|PASG (Passage Bio, Inc.) - Earnings growth forecast for next year|bionomics.com.au - Net earnings per share change forecast for next year|Earnings growth forecast for next year NERV|ATHA (Athira) - Expected earnings per share trend next year|Addex Therapeutics - Expected earnings per share growth for next year|ALZN - Expected earnings per share growth for next year|Cyclerion Therapeutics, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year CRGT|Expected earnings per share growth for next year ATXI|Expected earnings per share growth for next year Brainstorm Cell (BCLI)|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|Expected earnings per share growth for next year Chromocell Therapeutics Corp CHRO|Earnings growth forecast for next year ELYM (Eliem Therapeutics, Inc.)|Earnings growth forecast for next year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth forecast for next year|NeuroBo Pharmaceuticals Inc - Expected earnings per share trend next year|SAGE (Sage Therapeutics Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year SNPX (Neurotrope)|Net earnings per share growth forecast for next year Trevena Inc. (TRVN)|VIGL - Expected net earnings per share growth next year|Anew Medical Inc. - Expected earnings per share growth for next year|CERE (Cerevel Therapeutics, Inc.) - Net earnings per share change forecast for next year
